Fuel Use: Insulin Action on Liver and Adipose Tissues PDF
Document Details
Uploaded by ShinyLongBeach6025
University of Dundee
Prof Graham Rena
Tags
Summary
This document provides an overview of insulin's impact on fuel use in the liver and adipose tissues, covering topics such as learning objectives, homeostasis, physiological actions, and the insulin signaling pathway. It touches on the relationship between insulin actions and diabetes.
Full Transcript
Fuel Use: Insulin action on liver and adipose tissues Diabetes photo museum Prof Graham Rena Learning objectives for this topic Name the hormones involved in regulating blood glucose Describe what these hormones do to the body (their physiological action...
Fuel Use: Insulin action on liver and adipose tissues Diabetes photo museum Prof Graham Rena Learning objectives for this topic Name the hormones involved in regulating blood glucose Describe what these hormones do to the body (their physiological actions) Detail how these hormones work (the molecular mechanisms of their action) including – Actions on the liver and adipose Homeostasis: Normal blood glucose level 3.9-5.9 mmols/l GR glucose uptake into cells Insulin as glucose cre pan glycogen [glucose]blood falls to glycogen Stimulus normal range synthesis in [glucose]blood liver Imbalan ce GR as cre pan Homeostasis: Normal blood glucose level 3.9-5.9 mmols/l GR Physiological actions of insulin glucose uptake into cells glycogenesis (formation of glycogen for storage) in skeletal muscle and liver glycogenolysis (breakdown of glycogen to glucose) gluconeogenesis (formation of glucose from non-carbohydrate precursors) Net effect is a of blood glucose INSULIN-only hormone that blood glucose levels Glucose Insulin The insulin signalling pathway uptake PtdIns PI3 (3,4,5)P PDK PH P IRS P K p110 1 receptor 3 mTOR Insulin p85 PH C2 P P GSK3 P Akt glycogen inhibition synthesis P p70S6 FOXO P K GLUT4 gluconeogenic (adipose/muscle) Protein gene expression 7 translocation translation Glucose Insulin Insulin signal transduction is uptake mediated by a protein kinase cascade to Akt PtdIns PI3 (3,4,5)P PDK receptor PH P IRS P K p110 3 1 Insulin p85 mTOR PH C2 P P glycogen Akt synthesis gluconeogenic Protein gene expression 8 translation Glucose Insulin Akt mediates many of the pleiotropic uptake responses to insulin by regulation of many targets PtdIns PI3 (3,4,5)P PDK receptor PH P IRS P K p110 3 1 Insulin p85 mTOR PH PH C2 P P glycogen Akt synthesis gluconeogenic Protein gene expression 9 translation Glucose Insulin GSK3 regulates hepatic glycogen uptake synthesis PtdIns PI3 (3,4,5)P PDK receptor PH P IRS P K p110 3 1 Insulin p85 mTOR PH PH C2 P P GSK3 glycogen inhibition Akt synthesis gluconeogenic Protein gene expression 10 translation Glucose Insulin GSK3 regulates hepatic glycogen uptake synthesis PtdIns PI3 (3,4,5)P PDK receptor PH P IRS P K p110 3 1 Insulin p85 mTOR PH PH C2 P P GSK3 P glycogen inhibition Akt synthesis gluconeogenic Protein gene expression 11 translation Glucose Insulin FOXO regulates hepatic uptake gluconeogenesis PtdIns PI3 (3,4,5)P PDK receptor PH P IRS P K p110 3 1 Insulin p85 mTOR PH PH C2 P P GSK3 P glycogen inhibition Akt synthesis gluconeogenic FOXO P Protein gene expression 12 translation How FOXOs are inactivated (IGF-1 + serum) How FOXOs are inactivated (IGF-1 + serum) Glucose Insulin GLUT4 translocation mediates insulin- uptake stimulated glucose uptake (muscle/adipocyte) PtdIns PI3 (3,4,5)P PDK receptor PH P IRS P K p110 3 1 Insulin p85 mTOR PH PH C2 P P GSK3 P glycogen inhibition Akt synthesis FOXO P GLUT4 gluconeogenic Protein translocation gene expression 15 translation to cell Glucose Insulin Some aspects of insulin action impact uptake on fuel use more broadly than glucose regulation PtdIns PI3 (3,4,5)P PDK receptor PH P IRS P K p110 3 1 Insulin p85 mTOR PH PH C2 P P GSK3 P glycogen inhibition Akt synthesis P p70S6 FOXO P K GLUT4 gluconeogenic Protein translocation gene expression 16 translation to cell KEY: Post-translational modification Insulin action on the hepatocy Allosteric regulation Glucose Gene expression GLUT2 Glucose Gluco Glycogen G-6-Pase - Kinase+ synthase+ Glucose-6-phosphate Free fatty acids Gluconeogenesis Glycogen Fructose-6-phosphate synthesis Glycolysis Fatty acid synthesis Fatty acid Fructose-1,6- PFK+ synthase + phosphatase- Fructose-1,6-bisphosphate Malonyl CoA PEPCK - Acetyl CoA PEP Carboxylase + Pyruvate Oxaloacetate kinase+ Acetyl CoA Pyruvate citrate Acetyl CoA Mitochondria KEY: Glycogen synthesis is stimulate Post-translational modification Allosteric regulation Glucose Gene expression GLUT2 Glucose Gluco Glycogen Kinase+ synthase+ Glucose-6-phosphate Glycogen synthesis KEY: Post-translational modification Glycolysis is stimulated Allosteric regulation Glucose Gene expression GLUT2 Glucose Gluco Glycogen Kinase+ synthase+ Glucose-6-phosphate Glycogen Fructose-6-phosphate synthesis Glycolysis PFK+ Fructose-1,6-bisphosphate PEP Pyruvate kinase+ Pyruvate Acetyl CoA Mitochondria KEY: Post-translational modification Gluconeogenesis is suppresse Allosteric regulation Glucose Gene expression GLUT2 Glucose Gluco Glycogen G-6-Pase - Kinase+ synthase+ Glucose-6-phosphate Gluconeogenesis Glycogen Fructose-6-phosphate Gluco=glucose, synthesis Glycolysis Fructose-1,6- PFK+ phosphatase- neo=new, Fructose-1,6-bisphosphate genesis=production. PEPCK - PEP Pyruvate Oxaloacetate kinase+ Pyruvate citrate Acetyl CoA Mitochondria KEY: Futile cycling suppressed alloster Post-translational modification Allosteric regulation Glucose Gene expression GLUT2 Prevention of futile Glucose Gluco Glycogen cycling by PFK2/FBPase-2 G-6-Pase - Kinase+ synthase+ Glucose-6-phosphate Gluconeogenesis Glycogen Fructose-6-phosphate synthesis Glycolysis Fructose-1,6- PFK+ phosphatase- Liver PFK2 Fructose-1,6-bisphosphate F6P F2,6P PEPCK - PEP Pyruvate Liver FBPase-2 Oxaloacetate kinase+ Pyruvate citrate Acetyl CoA Mitochondria KEY: Futile cycling suppressed alloster Post-translational modification Allosteric regulation Glucose Gene expression GLUT2 Prevention of futile Glucose Gluco Glycogen cycling by PFK2/FBPase-2 G-6-Pase - Kinase+ synthase+ Glucose-6-phosphate Insulin promotes dephosphorylation Gluconeogenesis Glycogen of PFK2/FBPase-2 Fructose-6-phosphate synthesis Glycolysis Fructose-1,6- PFK+ phosphatase- Liver PFK2 Fructose-1,6-bisphosphate (dephospho) F6P F2,6P PEPCK - PEP Pyruvate Liver FBPase-2 Oxaloacetate kinase+ (dephospho) Pyruvate citrate Acetyl CoA Mitochondria KEY: Post-translational modification Futile cycling suppressed allosterica Allosteric regulation Glucose Gene expression GLUT2 Prevention of futile Glucose Gluco Glycogen cycling by PFK2/FBPase-2 G-6-Pase - Kinase+ synthase+ Glucose-6-phosphate Glucagon induces phosphorylation Gluconeogenesis Glycogen of PFK2/FBPase-2 Fructose-6-phosphate synthesis Glycolysis Fructose-1,6- PFK+ phosphatase- Liver PFK2 Fructose-1,6-bisphosphate (phospho) F6P F2,6P PEPCK - PEP Pyruvate Liver FBPase-2 Oxaloacetate kinase+ (phospho) Pyruvate citrate Acetyl CoA Mitochondria KEY: Post-translational modification Fatty acid synthesis is promot Allosteric regulation Glucose Gene expression GLUT2 Glucose Gluco Glycogen G-6-Pase - Kinase+ synthase+ Glucose-6-phosphate Fatty acids Gluconeogenesis Glycogen Fructose-6-phosphate synthesis Glycolysis Fatty acid synthesis Fatty acid Fructose-1,6- PFK+ synthase + phosphatase- Fructose-1,6-bisphosphate Malonyl CoA PEPCK - Acetyl CoA PEP Carboxylase + Pyruvate Oxaloacetate kinase+ Acetyl CoA Pyruvate citrate Acetyl CoA Mitochondria Production and transport of very low-density lipoprotein (VLDL) and fatty acid (FA) between liver and VLDL adipose tissue Lipoprotein lipase+ Fatty acids LIVER VLDL FA+glycerol TG Fatty acids + ADIPOSE glycerol TG FA+glycerol HSL- Free fatty acids KEY: Post-translational modification Dysregulation of these transport mechanisms in diabetes Allosteric regulation causes hyperlipidaemia Gene expression Overview of Insulin Action Insulin: – Promotes glucose uptake into liver – Promotes glucose storage as glycogen – Promotes glucose use in glycolysis/TCA cycle AND suppresses gluconeogenesis – Promotes glucose conversion into fatty acids which are shipped to the adipose tissue – Suppresses triglyceride breakdown in the adipose tissue – Insulin treatment in diabetes tends to result in weight gain Fuel Use: 1. Counterregulation & 2. Diabetes Counterregulation Homeostasis: Normal blood glucose level 3.9-5.9 mmols/l GR glucose uptake into cells Insulin as glucose cre pan glycogen [glucose]blood falls to glycogen Stimulus normal range synthesis in [glucose]blood liver Imbalan ce GR as cre pan Homeostasis: Normal blood glucose level 3.9-5.9 mmols/l GR Imbalan ce [glucose]blood Stimulus [glucose]blood rises to normal range glucose glycogen as cre pan glycogen breakdown to glucagon glucose in liver GR Homeostasis: Normal blood glucose level 3.9-5.9 mmols/l as cre pan GR glucose uptake into cells Insulin as glucose cre pan glycogen [glucose]blood falls to glycogen Stimulus normal range synthesis in [glucose]blood liver Imbalan ce [glucose]blood Stimulus [glucose]blood rises to normal range glucose glycogen as cre pan glycogen breakdown to glucagon glucose in liver GR Overview of Glucagon Action Glucagon opposes many of the regulatory effects of insulin through its own second messenger cAMP – Increases glycogenolysis – Increases gluconeogenesis – Suppresses glycolysis – Increases FA oxidation – In adipose tissues stimulates HSL Glucagon is first-line in a battery of counter-regulatory responses! International textbook on Diabetes Mellitus (Wiley) Eds: DeFronzo, Ferrannini, Keen, Zimmet 35 Diabetes mellitus Most common of all endocrine disorders Major feature = hyperglycaemia blood glucose (>200mg/100ml; > 16mmol/l) Glucosuria = glucose in urine with large osmotic diuresis – dehydration – circulatory failure, brain damage & renal failure Following a meal, many cells cannot take up glucose properly – Extracellular glucose high – Intracellular glucose deficiency Diabetes mellitus Before insulin there were a variety of dietary treatments including starvation diets. “Children hovered miserably between death from diabetes and death from starvation. One 12- year-old boy, already blind from diabetes, was reduced to eating toothpaste mixed with birdseed stolen from his pet canary. ‘These facts were obtained by confession after long and plausible denials’, remarked the pitiless Allen [the child’s physician]. The unfortunate child died of starvation.”Sawyer and Gale (2009) Diabetologia 52: 1-7) ( Eli Lilly and company archives Diabetes mellitus Before insulin there were a variety of dietary treatments including starvation diets. “Children hovered miserably between death from diabetes and death from starvation. One 12- year-old boy, already blind from diabetes, was reduced to eating toothpaste mixed with birdseed stolen from his pet canary. ‘These facts were obtained by confession after long and plausible denials’, remarked the pitiless Allen [the child’s physician]. The unfortunate child died of starvation.”Sawyer and Gale (2009) Diabetologia 52: 1-7) ( Eli Lilly and company archives Criteria for Diabetes WHO Criteria for Diabetes: FPG ≥ 7.0mmol/l OGTT (2hrs) ≥ 11.1mmol/l after 75g glucose load IGT = (FPG 8.5 mmol/L (2-hour OGTT) HbA1C ADA: Diabetes Diagnosis: HbA1C >6.5% Pre-diabetes: 5.7-6.4% WHO “The HbA1c result is influenced by several factors including anaemia, abnormalities of haemoglobin, pregnancy and uraemia. Some of these factors may be a bigger problem in under-resourced countries due to a higher prevalence of anaemia and of haemoglobinopathies” WHO Diabetes Criteria What is the definition for type 1 diabetes? What is the definition for type 2 diabetes? Is there anything else? WHO Types of Diabetes T1DM- pancreatic beta cell destruction/ insulin is required for survival - usually characterised by the presence of anti-GAD/ anti-islet cell antibodies T2DM- ‘a person is normally thought to have type 2 diabetes if he or she doesn’t have type 1 diabetes, monogenic diabetes or other medical condition or treatment suggestive of secondary diabetes’ i.e. a diagnosis of exclusion MODY (monogenic) Secondary Causes: e.g. drugs, pancreatic pathology, endocrine cause Diabetes-type 1 vs type 2 Type 1 Type 2 Insulin status No insulin Normal or increased Age of onset Childhood Adulthood Defect Loss of b cells Sensitivity of cells to insulin INSULIN RESISTANCE Obesity? No Yes Speed of development Fast Slow Dyslipidaemia No Plasma TG HDL cholesterol Small dense LDL cholesterol Production and transport of very low-density lipoprotein (VLDL) and fatty acid (FA) between liver and VLDL adipose tissue Lipoprotein lipase+ Fatty acids LIVER VLDL FA+glycerol TG Fatty acids + ADIPOSE glycerol TG FA+glycerol HSL- Free fatty acids KEY: Post-translational modification Dysregulation of these transport mechanisms in Allosteric regulation diabetes causes hyperlipidaemia Gene expression Learning Outcomes We found out what insulin does. (We found out that insulin has a variety of physiological actions which lower blood glucose) We learned how insulin secretion after a meal acts on: Fatty acid synthesis, glycogen synthesis and gluconeogenesis in the liver and triglyceride storage in adipose tissue through-insulin signal transduction Glucagon and other counterregulatory hormones oppose many of these effects We defined the main types of diabetes